glp-1 and macular degeneration Do glp1 drugs cause degeneration? GLP-1 receptor agonists in eye

JAMA Netw Open 2024;7(7): e2421305.

So there's heightened anxiety on either side of the issue

Int j Obes 1999

The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin

In the Phase 2 Lancet trial, orforglipron 45 mg reduced HbA1c by up to 2.1 percentage points at 26 weeks, exceeding the reduction achieved by dulaglutide 1.5 mg (the active comparator)

We are talking about hours, not days